RP

Reddi Padma

Active Director Director DIN 07517565
DIN 07517565 First appointment May 2016 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2016
Shareholding value •••• Premium profile

About Reddi Padma

Data last updated:

Reddi Padma is a Director at Macto Pharmaceuticals Private Limited (since 2016). The company operates in Pharma. Macto Pharmaceuticals Private Limited reported revenue of ₹54.3 Lakh (FY 2025).

DIN 07517565
Primary Designation Director
Industry Pharma
First Appointment 18 May 2016
Oldest Company Age 11 yrs
Largest company Macto Pharmaceuticals Private Limited · ₹54.3 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director18 May 20162015₹54.3 Lakh (FY 2025)Active

Board colleagues of Reddi Padma

Directorship timeline

Open interactive timeline →
Macto Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Reddi Padma

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Reddi Padma

Reddi Padma currently holds 1 directorship: Macto Pharmaceuticals Private Limited (Director, since 18 May 2016, revenue ₹54.3 Lakh (FY 2025)).

Reddi Padma was first appointed on 18 May 2016 as Director at Macto Pharmaceuticals Private Limited.

The current boards of Reddi Padma's companies include Pilla Krishna Priya (Macto Pharmaceuticals Private Limited), Someswara Rao Bokam (Macto Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available